120 related articles for article (PubMed ID: 34474024)
1. Prognostic Value of Uncertain Resection for Overall Survival in Non-small Cell Lung Cancer.
Kadomatsu Y; Nakamura S; Ueno H; Goto M; Ozeki N; Fukumoto K; Fukui T; Suzuki Y; Chen-Yoshikawa TF
Ann Thorac Surg; 2022 Oct; 114(4):1262-1268. PubMed ID: 34474024
[TBL] [Abstract][Full Text] [Related]
2. Beyond Margin Status: Population-Based Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification Recategorization.
Osarogiagbon RU; Faris NR; Stevens W; Fehnel C; Houston-Harris C; Ojeabulu P; Akinbobola OA; Lee YS; Ray MA; Smeltzer MP
J Thorac Oncol; 2020 Mar; 15(3):371-382. PubMed ID: 31783180
[TBL] [Abstract][Full Text] [Related]
3. A Validation Study of the Recommended Change in Residual Tumor Descriptors Proposed by the International Association for the Study of Lung Cancer for Patients With pN2 NSCLC.
Yun JK; Lee GD; Choi S; Kim YH; Kim DK; Park SI; Kim HR
J Thorac Oncol; 2021 May; 16(5):817-826. PubMed ID: 33607310
[TBL] [Abstract][Full Text] [Related]
4. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer.
Edwards JG; Chansky K; Van Schil P; Nicholson AG; Boubia S; Brambilla E; Donington J; Galateau-Sallé F; Hoffmann H; Infante M; Marino M; Marom EM; Nakajima J; Ostrowski M; Travis WD; Tsao MS; Yatabe Y; Giroux DJ; Shemanski L; Crowley J; Krasnik M; Asamura H; Rami-Porta R;
J Thorac Oncol; 2020 Mar; 15(3):344-359. PubMed ID: 31731014
[TBL] [Abstract][Full Text] [Related]
5. Prognostic evaluation of the proposed residual tumor classification in a Chinese non-small cell lung cancer population.
Ren Y; She Y; Tang H; Deng J; Jiang G; Wu C; Zhu Y; Zheng H; Chen C
J Surg Oncol; 2022 May; 125(6):1061-1070. PubMed ID: 35099810
[TBL] [Abstract][Full Text] [Related]
6. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
[TBL] [Abstract][Full Text] [Related]
7. Residual tumor descriptors proposed by the International Association for the Study of Lung Cancer may not be applicable to stage I and ground-glass opacity-featured non-small cell lung cancer.
Wen Z; Fu F; Zhao Y; Gao Z; Han H; Li H; Ye T; Hu H; Sun Y; Li Y; Zhang Y; Chen H
Transl Lung Cancer Res; 2023 Nov; 12(11):2157-2168. PubMed ID: 38090514
[TBL] [Abstract][Full Text] [Related]
8. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
[TBL] [Abstract][Full Text] [Related]
10. Validation of the IASLC Residual Tumor Classification in Patients With Stage III-N2 Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed By Surgery.
Lee J; Lee J; Hong YS; Lee G; Kang D; Yun J; Jeon YJ; Shin S; Cho JH; Choi YS; Kim J; Zo JI; Shim YM; Guallar E; Cho J; Kim HK
Ann Surg; 2023 Jun; 277(6):e1355-e1363. PubMed ID: 35166266
[TBL] [Abstract][Full Text] [Related]
11. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of the Proposed Residual Tumor Classification in Patients With NSCLC After Sleeve Lobectomy.
Chen T; Zhong Y; Wen J; Deng J; She Y; Zhu Y; Chen Q; Wu C; Hou L; Jiang L; Chen C
JTO Clin Res Rep; 2023 Oct; 4(10):100574. PubMed ID: 37822700
[TBL] [Abstract][Full Text] [Related]
13. Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.
Qiao R; Zhong R; Xu J; Zhang Y; Zhang B; Wang S; Lou Y; Chen D; Chang Q; Zhao Y; Han B
J Cardiothorac Surg; 2019 Mar; 14(1):63. PubMed ID: 30925891
[TBL] [Abstract][Full Text] [Related]
14. Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis.
Kuroda H; Sakao Y; Mun M; Uehara H; Nakao M; Matsuura Y; Mizuno T; Sakakura N; Motoi N; Ishikawa Y; Yatabe Y; Nakagawa K; Okumura S
PLoS One; 2015; 10(8):e0134674. PubMed ID: 26247881
[TBL] [Abstract][Full Text] [Related]
15. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
[TBL] [Abstract][Full Text] [Related]
17. Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection.
Matsumura Y; Hishida T; Yoshida J; Aokage K; Ishii G; Nagai K
J Thorac Oncol; 2012 Nov; 7(11):1691-7. PubMed ID: 23059781
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
19. [Postoperative survival analysis of patients with stage Ⅲ-pN2 non-small cell lung cancer].
Wu XW; Chen T; Yin S; Deng Y; Zhao B
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):782-786. PubMed ID: 30392344
[No Abstract] [Full Text] [Related]
20. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
